2019 Agenda


Tuesday, April 2, 2019

11:00 AM
REGISTRATION OPENS
2:00 PM
WELCOME
2:05 PM
UNDERSTANDING HEALTH’S BOTTOM LINE—AND IMPROVING IT

It’s relatively easy to determine whether companies are profitable or not. They pull in more revenue than they spend. But finding the bottom line for human health is far more challenging. What makes us healthy? How do we know when we are healthy? What are the line items that we should be examining and improving if necessary? This isn’t just a personal puzzle to solve, but one for the entire business community to understand. We talk a lot about the business of health, but it may be the only business where we have little clue about what the bottom line is.

Dr. David B. Agus, Co-chair, FORTUNE Brainstorm Health; Professor of Medicine and Engineering; Founding Director and CEO, Lawrence J. Ellison Institute, Transformative Medicine, University of Southern California
Arianna Huffington, Founder and CEO, Thrive Global; Co-chair, FORTUNE Brainstorm Health
Clifton Leaf, Editor-in-Chief, FORTUNE; Co-chair, Brainstorm Health

2:15 PM
A BOLDER METRIC: EXTENDING HEALTHY LIVING

For the first time in history, most people can expect to live into their sixties and beyond. Advances in technology and research are helping humans live longer, but does living a long life mean we’ve led a healthy one? Kaiser Permanente’s CEO Bernard J. Tyson explores a new metric for healthy living. He shares the big bets the company is making to improve health outcomes and lower the cost of care for its 12 million members.

Bernard J. Tyson, Chairman and CEO, Kaiser Permanente
Interviewer: Clifton Leaf, FORTUNE

2:35 PM
BIG DATA ONE: EMPOWERING MACHINES

A look at how artificial intelligence, robotics, and cognitive computing are disrupting health care today. As machines become smarter, how are hospitals, operating rooms, and doctors’ offices transforming? How will advances in A.I. and robotics improve our overall health, prevent illness before it starts, and get us on track to live healthier lives? A conversation about A.I., the game changer, and what its advances mean for health care’s bottom line.

Dr. Gianrico Farrugia, President and CEO, Mayo Clinic
Dr. John Kelly III, Executive Vice President, IBM
Dr. Mona Siddiqui, Chief Data Officer, U.S. Department of Health and Human Services
Moderator: Dr. David B. Agus, USC

3:00 PM
HOW A.I. CAN MAKE HEALTH CARE HUMAN AGAIN

Putting the “person” back in personalized medicine. Leading physician Dr. Eric Topol shares the key takeaways from his new book, Deep Medicine, why he believes the doctor-patient relationship is broken, and how A.I. has the potential to fix it.

Dr. Eric Topol, Founder and Director, Scripps Research Translational Institute
Interviewer: Clifton Leaf, FORTUNE

3:10 PM
BIG DATA TWO: IS BIG DATA THE CURE, PLACEBO… OR PLAGUE?

New technologies—from A.I. to robotics—are generating enormous amounts of data when it comes to our health. This tsunami of data is helping us make big strides in early intervention, personalized treatment, and medical research. But at what cost? How can we keep our sensitive medical data out of the wrong hands? And what will the future of health care look like as we increasingly rely on big data to diagnose, treat, and predict future medical issues? A look at the duality of data and how it can both help and hinder the health care ecosystem.

Eric Lefkofsky, Founder and CEO, Tempus
Dr. Jessica Mega, Chief Medical Officer and Scientific Officer, Verily Life Sciences
Dr. Eric Topol, Founder and Director, Scripps Research Translational Institute
Moderator: Michal Lev-Ram, Senior Writer, FORTUNE

3:40 PM
BREAK
4:05 PM
LEARNING HOW STRESS AND ANXIETY CAN BE YOUR FRIENDS

Nearly 80% of Americans say they’re stressed out, while close to half of us say our anxiety levels are up from a year ago. And, for many, we’re now stressed about stressing out and anxious about our anxiety. The good news? Stress and anxiety can be your friends. Leading psychologist Dr. Lisa Damour, author of the New York Times bestseller Under Pressure: Confronting the Epidemic of Stress and Anxiety in Girls, shares the upside of these mental states, how you can’t thrive without them, and why both stress and anxiety are necessary for human growth and development.

Dr. Lisa Damour, Senior Adviser, Schubert Center for Child Studies, Case Western Reserve University; Executive Director, Laurel School’s Center for Research on Girls

4:13 PM
CORPORATE MAKEOVERS: REIMAGINING EMPLOYEE HEALTH

As the cost of health care continues to rise, some of the nation’s biggest employers are taking charge and becoming important agents of change. From new health care ventures to updated insurance contracts and technology-driven care, companies are finding novel ways to cover workers and keep health care costs at bay. An exploration of how companies are leading the charge—especially thanks to improvements in data, analytics, and changes in mindset—to reduce health care costs and create better outcomes.

Marcie Frost, Chief Executive Officer, California Public Employees’ Retirement System
Jennifer Morgan, Executive Board Member; President, Americas and Asia Pacific Japan, Global Customer Operations, SAP
Jared Smith, Co-founder, Qualtrics
Marvelle Sullivan Berchtold, Chief Executive Officer, Marvelle Co.
Moderator: Arianna Huffington, Thrive Global

4:48 PM
BETTING ON THE NEW BUSINESS MODELS

With new entrants such as Amazon and Walmart taking bold steps in the health care sector, and major acquisitions by Cigna and CVS, business models and the entire health care landscape are undergoing seismic shifts. New technologies—from A.I. to 5G—are transforming what we once thought impossible into everyday realities, moving the epicenter of health care from the doctor’s office to the smartphone and putting consumers more in charge of their well-being than ever before. All of these technologies have caused major changes to the grand multi-trillion dollar enterprise of medicine and given birth to a host of new business models and ways of connecting patients with providers and payers.

Bruce Broussard, President and CEO, Humana
Dr. Paul Jacobs, Chairman and CEO, XCOM; Chairman, Heal
Moderator: Dr. Toby Cosgrove, Executive Adviser, Cleveland Clinic; Executive Adviser, Google Cloud Healthcare and Life Sciences

5:13 PM
DATA THAT MAKES DOCTORS BETTER

A behind-the-curtain look at one A.I. technology that’s already transforming patient care. Israeli company Zebra Medical—which has FDA approval for heart disease detection—uses its A.I. algorithms to detect misdiagnosed diseases and early-stage cancers. Zebra’s CEO Eyal Gura shares how the technology catches medical issues, and how it doesn’t replace doctors but rather helps make them more efficient.

Eyal Gura, CEO and Chairman, Zebra Medical Vision

5:18 PM
A TECHNOLOGIST’S TAKE ON HEALTHCARE, 2019

Othman Laraki, Co-founder and CEO, Color

5:23 PM
CHANGING THE R&D PARADIGM

As we transform drug development in the age of A.I., fine-tuning our patient understanding will be more important than ever. When it comes to R&D, the challenge before us is to become experts at measuring disease—and disease progression—in order to treat it. A discussion with one of the leading minds in R&D on this new imperative.

Dr. Hal Barron, Chief Scientific Officer and President, Research & Development, GSK
Interviewer: Dr. David B. Agus, USC

5:33 PM
DRONES THAT SAVE LIVES

Since its launch in 2016, Zipline drones have logged more than 300,000 miles, delivering thousands of units of blood and saving countless lives. But this technology is not just for developing countries. Zipline could also transform remote areas of the United States, where the maternal mortality rate is the highest in the developed world. A demo about how drones can save lives in remote areas, not only abroad but right here at home.

Keller Rinaudo, Co-founder and CEO, Zipline

5:40 PM
A GLOBAL APPROACH: CURING THE INCURABLE THROUGH TECHNOLOGY AND TEAMWORK

How technology and innovation can address some of the world’s most challenging problems, especially when for-profit companies, nonprofit organizations, and government work in concert with deliberate speed. A conversation about how collaboration and ingenuity can tackle global health care challenges—from developing lifesaving vaccines to using data from cell phones and satellites to stop the spread of deadly diseases.

Dr. Caroline Buckee, Associate Professor of Epidemiology and Associate Director, Center for Communicable Disease Dynamics, T.H. Chan School of Public Health, Harvard University
Dr. Julie Gerberding, Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health, Merck
Dr. Carla Kriwet, Executive Vice President and CEO, Connected Care, Royal Philips
Peter Sands, Executive Director, The Global Fund for AIDS, Tuberculosis and Malaria
Moderator: Alan Murray, President and CEO, FORTUNE

6:10 PM
RECEPTION
7:00 PM
DINNER AND FEATURED INTERVIEW

Introduction: Dr. John Kelly III, Executive Vice President, IBM

SPECIAL PERFORMANCE AND INTERVIEW: DARRIUS SIMMONS
Eighteen-year-old Darrius Simmons was born with three fingers on his right hand and just one on his left. He wears prosthetic legs, after both of his legs were amputated when he was a toddler. But as Darrius proved at his 2016 Carnegie Hall debut, all he really needs to play piano is heart. Here, straight from Warren G. Harding High School in Ohio—playing an original composition that will make your own heart sing—is Darrius Simmons.

Darrius Simmons, Pianist
Interviewer: Arianna Huffington, Thrive Global

AN UNFORGETTABLE, UNREASONABLE, AND—THANKFULLY—NOT IMPOSSIBLE CONVERSATION
President John F. Kennedy declared nearly 60 years ago, “We choose to go to the moon in this decade and do the other things, not because they are easy, but because they are hard…” JFK’s famous words could well be the mantra for two young, visionary leaders who are solving the problems that many of us assumed were impossible—or unreasonable—to tackle. An outrageous discussion with the change-agents focused on some of the world’s most challenging humanitarian, environmental, and social issues.

Mick Ebeling, Founder and CEO, Not Impossible Labs
Daniel Epstein, Founder and CEO, Unreasonable
Moderator: Clifton Leaf, FORTUNE

9:00 PM
CLOSE

Wednesday, April 3, 2019

6:45 AM
EARLY MORNING MEDITATION

Location: Movement Studio

Led by: Agapi Stassinopoulos, Author, Unbinding the Heart and Wake Up to the Joy of You

7:00 AM
REGISTRATION OPENS
7:30 AM
CONCURRENT BREAKFASTS

DROWNING IN DATA, GASPING FOR INSIGHT
Transformative Technologies Track Hosted by Intel
By some counts, the sheer volume of health care data could reach 2,314 exabytes (a single exabyte being equal to one billion gigabytes) by 2020. But this avalanche of information won’t necessarily foster knowledge, if history is any guide. Just 39% of doctors and 36% of patients used basic tools like patient health portals in 2018, for instance. And a massive swath of collected health data is never used at all. How can we transform the information at our command into actionable insight?

Chris Gough, General Manager, Health and Life Sciences, Intel
Eyal Gura, CEO and Chairman, Zebra Medical Vision
Dave Hodgson, Co-founder and CEO, Project Ronin
Dr. Jessica Mega, Chief Medical and Scientific Officer, Verily Life Sciences
Dr. Jennifer Schneider, President, Livongo
Moderator: Sy Mukherjee, Writer, FORTUNE

SMARTEST HEALTH CARE INVESTMENTS FOR TODAY… AND TOMORROW
Hosted by Herman Miller
2018 was a super-charged, headline-driven year for health care investors, with a frenzy of activity in mergers and acquisitions, biotech IPOs, and venture funding. How is the health care landscape changing, and where’s the best place for investors to place their bets? A discussion about the smartest place to put your money in a sector undergoing major disruption.

Jorge Conde, General Partner, Andreessen Horowitz
Rajiv Kaul, Biotechnology Portfolio Manager, Fidelity Investments
Camille Samuels, Partner, Venrock
Dr. Beth Seidenberg, Founding Managing Director, Westlake Village BioPartners
Amit Sinha, Managing Director, Global Head of Biotechnology Investment Banking, Goldman Sachs
Moderator: Michal Lev-Ram, FORTUNE
Introduction: Mike O’Toole, Senior Vice President, Healthcare & Education, Herman Miller

REVOLUTIONIZING WELL-BEING IN THE WORKPLACE
Hosted by SAP
$300 billion a year. That’s how much work-related stress continues to cost U.S. companies in lost productivity. With much of today’s workforce always feeling the need to be “on” and rarely getting the necessary rest to perform at their best, a majority of organizations, not surprisingly, view employee well-being in the workplace as an essential component of their business strategy. So, how can companies best create a culture that acknowledges the link between well-being and performance? A roundtable discussion on ways that employers can realize the full human potential of their workforce and ultimately improve both the employee experience and the company’s bottom line.

Jay Fulcher, Chairman and CEO, Zenefits
Dr. Megan Jones Bell, Chief Science Officer, Headspace
Prof. Olivier Oullier, President, EMOTIV
Marvelle Sullivan Berchtold, Chief Executive Officer, Marvell Co.
Moderator: Erika Fry, Senior Writer, FORTUNE
Introduction: Kirsten Allegri Williams, Chief Marketing Officer, SAP SuccessFactors

TRUST: THE MISSING INGREDIENT IN HEALTH CARE TODAY
A virulent anti-vaccine movement is putting Americans in danger—and it shows no sign of abating. It’s only one way that Americans seem to be losing trust in the health care system. Scandalous billing practices, sky-high drug prices, the ethics of digital health and high-profile frauds like Theranos are making many lose faith that medicine is on their side. How can we change this?

Dr. Julie Gerberding, Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health, Merck
Dr. Jodi Halpern, Professor of Bioethics and Medical Humanities, UC Berkeley
Dr. David Kessler, Professor of Pediatrics and Epidemiology and Biostatistics, School of Medicine, University of California San Francisco
Dr. George Savage, Co-founder and Chief Medical Officer, Proteus Digital Health
Moderator: Dr. Elisabeth Rosenthal, Editor-in-Chief, Kaiser Health News; Author, An American Sickness

8:45 AM
SWITCH BREAK
9:00 AM
WELCOME BACK
9:05 AM
WHY WE HAVE TO MEASURE HEALTH

Measuring what matters. A look at how we can best utilize precision across the board in health care. We’ll hear from leaders of pharma, health systems, and payers, and explore how the right data can move the needle, improve outcomes, and lower costs.

Dr. Toby Cosgrove, Executive Adviser, Cleveland Clinic; Executive Adviser, Google Cloud Healthcare and Life Sciences
Dr. Freda Lewis-Hall, Executive Vice President and Chief Patient Officer, Pfizer
Dr. Jaewon Ryu, Interim President and CEO, Geisinger
Moderator: Dr. Lloyd Minor, Carl and Elizabeth Naumann Dean, Stanford University School of Medicine

9:30 AM
THE URGENCY OF A CURE: SPECIAL MESSAGE FROM MICHAEL J. FOX
9:45 AM
FERTILE GROUND: THE SCIENCE OF NEW BEGINNINGS

According to current CDC data, 12% of reproductive-age women in the U.S. have fertility problems. And, with American women having fewer babies and at older ages than at any time in the past 30 years, new approaches to fertility need to be addressed. An upstream look at how tech companies are tackling women’s reproductive health. We’ll be joined by leading voices from medicine and startups working together toward a more fertile future.

Gina Bartasi, Founder and CEO, Kindbody
Carly Leahy, Co-founder and Chief Creative Officer, Modern Fertility
Kate Ryder, Founder and CEO, Maven
Moderator: Dr. Jennifer Conti, Clinical Assistant Professor, Ob/Gyn, Stanford University School of Medicine

10:10 AM
RADICAL APPROACHES TO ALZHEIMER’S

The story of Alzheimer’s drug development has been one of consistent, and expensive, disappointment. Experimental treatments from drug makers like Eli Lilly, Merck, Axovant, Takeda, and Johnson & Johnson have failed in the past two years alone, costing the companies millions of dollars while dealing a blow to those hoping for scientists to discover an effective treatment. This string of failures has raised questions about whether the current R&D approach needs a fundamental makeover—either by focusing on prevention, different biological targets, or other shifts from the status quo. That’s why some biotech upstarts are focusing on new approaches to this public health quagmire—and could wind up changing the entire industry’s approach if they succeed.

Dr. Paul Alan Cox, Chief Executive Officer, Brain Chemistry Labs
Mei Mei Hu, Co-founder and CEO, United Neuroscience
Moderator: Clifton Leaf, FORTUNE

10:30 AM
HOW TO BREAK UP WITH YOUR PHONE

Is your phone the first thing you reach for in the morning and the last thing you touch before bed? Do you love your phone but also kind of hate it? Science journalist Catherine Price explains how our phones and apps are designed to manipulate our biochemistry. Learn how to create a long-term and sustainable relationship with your phone.

Catherine Price, Science Journalist and Author, How to Break Up With Your Phone

10:38 AM
HOW TO HACK OUR BRAINS INTO BETTER HEALTH

Our bad habits are expensive. Consider smoking and obesity, both of which lead to staggering health care costs globally. A mindful presentation on how we can train our brains and kick bad habits, from overeating to smoking to too much technology. We’ll learn why willpower fails and how neuroscience helps us leverage reward-based learning to hack our brains for sustainable, cost-effective behavior change.

Dr. Judson Brewer, Associate Professor and Director of Research and Innovation, Mindfulness Center, Brown University

10:46 AM
GUIDED MEDITATION: KEEP CALM AND CARRY ON

Tamara Levitt, Head of Mindfulness, Calm

10:56 AM
BREAK
11:20 AM
DEMO: TRACKING DISEASE AT OUR FINGERTIPS

With around 50,000 new cases of Parkinson’s disease diagnosed each year in the U.S. and no known cure, a new technology could offer some hope. IBM has created a wireless sensor that hugs one’s fingernail, recording and analyzing simple motions, gestures, finger-writing, and grip strength. The device was developed to measure the progression of Parkinson’s, but with grip strength as a key indicator of cognitive function in schizophrenics and cardiovascular health as well, the potential impact of this new biotech is limitless.

Dr. Ajay Royyuru, IBM Fellow and Vice President, Healthcare and Life Sciences Research, IBM

11:27 AM
CRISPR: THE GOOD, THE BAD, AND THE ETHICS OF GENE EDITING

Gene editing has the potential to eliminate genetic diseases, make crops more nutritious, and target viruses like HIV, but at what cost? In 2018, a Chinese scientist sparked international outrage after claiming he used CRISPR to make the first-ever gene-edited babies. It’s a tremendous leap for biotechnology, but how can this technology be used responsibly? What are the implications of designing our world on a molecular level? A conversation about how—and if—our ethics, laws, and boundaries can keep pace with CRISPR.

Dr. Udit Batra, Chief Executive Officer, MilliporeSigma; Executive Board Member; Merck KGaA, Darmstadt, Germany
Paul Dabrowski, Chief Executive Officer, Synthego
Dr. Rachel Haurwitz, President and CEO, Caribou Biosciences
Moderator: Sy Mukherjee, FORTUNE

11:50 AM
AMERICAN EPIDEMICS

Opioids. Vaping. Gun violence. Obesity. Each of these epidemics has a uniquely American flavor. How do we change the conversation about health behaviors in this country? Should the government do more—or less—than it has? And, how can corporations have a positive influence on public health and well-being?

Dr. Barbara Ferrer, Director, Los Angeles County Department of Public Health
Mindy Grossman, President and CEO, Director, WW
Dr. David Kessler, Former FDA commissioner; Professor of Pediatrics and Epidemiology and Biostatistics, School of Medicine, University of California San Francisco
Moderator: Dr. David B. Agus, USC

12:15 PM
GOING UPSTREAM: CHANGING BEHAVIOR FOR HEALTHIER LIVES

Treating diseases as they arise is one thing, but preventing health issues by changing one’s behavior is another. From life-changing sleep, to digital treatments and therapies, to daily care rituals including oral and sleep hygiene–upstream strategies are focused on being proactive rather than reactive, modifying our behaviors in order to improve our health. How are companies using connected technology platforms and highly accurate data in sleep, healthcare, and consumer products to help us move upstream? Hear from experts revolutionizing health care by adding meaningful value and helping us live healthier lives effortlessly.

Kathy Fish, Chief Research, Development and Innovation Officer, P&G
Shelly Ibach, President and CEO, Sleep Number
Dr. Deborah Kilpatrick, Chief Executive Officer, Evidation Health
Moderator: Arianna Huffington, Thrive Global

12:40 PM
HACKING MEDICINE

Groundbreaking science is often fueled by a sense of curiosity and commitment to the public welfare. But the search for pioneering medicines can also arise from more personal motivations. So it is for Rakuten chairman and CEO Mickey Mikitani, whose own father’s pancreatic cancer diagnosis spurred him to evangelize an experimental form of cancer treatment called photoimmunotherapy. This process combines an oncologic drug antibody conjugated to a dye that is activated by nonthermal red light illumination to induce rapid tumor cell death.

Mickey Mikitani, Chairman and CEO, Rakuten
Interviewer: Dr. David B. Agus, USC

12:55 PM
SWITCH BREAK
1:05 PM
CONCURRENT LUNCHES

HEALTH TECH’S BIGGEST DISRUPTORS: FROM AI TO VR, 5G, AND BEYOND
Transformative Technologies Track Hosted by Intel
Advanced technologies such as machine learning and virtual reality are here to stay, and they are revolutionizing the way we conduct medical research, deliver remote care, and tackle disease. But as the advances—from 5G to quantum computing—come with breakneck speed, will they reshape health care or simply bloat its cost? And, how can we overcome the barriers to technology adoption? In this candid roundtable, we’ll separate the buzz from the biz.

Megan Callahan, Vice President, Health Care, Lyft
Antigone Davis, Global Head of Safety, Facebook
Nick Desai, Co-founder and CEO, Heal
Sami Inkinen, Co-founder and CEO, Virta Health
Maria Lensing, Vice President, Healthcare Solutions, AT&T Business
Carolyn Magill, Chief Executive Officer, Aetion
Moderator: Michal Lev-Ram, FORTUNE
Introduction: Chris Gough, General Manager, General Manager, Health and Life Sciences, Intel

THE FOUNDERS LUNCH
A gathering of founders who have created promising new health care and technology companies, along with founders of leading nonprofits. What are some of the biggest obstacles they’ve overcome on the road to success? How can entrepreneurs find funding, understand the marketplace, and foster innovation within their companies? And, how can nonprofit organizations stay true to their mission while forging ahead? A roundtable discussion on how to turn an idea into a successful business model.

Deborah Brooks, Co-founder and Executive Vice Chairman, The Michael J. Fox Foundation for Parkinson’s Research
Amy DuRoss, Co-founder and CEO, Vineti
Mei Mei Hu, Co-founder and CEO, United Neuroscience
Serge Saxonov, Co-founder and CEO, 10x Genomics
Moderator: Brian O’Keefe, Editor-in-Chief, IBM Institute for Business Value, IBM

THE PROMISE AND THE PERIL OF ELECTRONIC HEALTH RECORDS
EHRs were meant to usher in an era of safer, seamless, higher-quality, and more cost-effective care. But instead, physicians (already experiencing epidemic levels of burnout) complain about clumsy, unintuitive systems and the number of hours spent clicking, typing, and trying to navigate them. Critics say the computerization of workflows has stifled human communication in health care settings. Plus, EHRs still don’t really talk to each other. All the while, patients struggle to access their complete medical record. Can we train or innovate our way out of this mess, or does the U.S. health care system have to fix itself first?

Erika Fry, Senior Writer, FORTUNE
Dr. Peter Lee, Corporate Vice President, Microsoft Healthcare
Kimber Lockhart, Chief Technology Officer, One Medical
Fred Schulte, John A. Hartford Senior Correspondent, Kaiser Health News
Greg Simon, President, Biden Cancer Initiative
Subject expert: Dr. Lloyd Minor, Carl and Elizabeth Naumann Dean, Stanford University School of Medicine
Moderator: Clifton Leaf, FORTUNE

2:20 PM
SWITCH BREAK
2:30 PM
DEMO: TREATING DEPRESSION, ANXIETY, AND INSOMNIA WITHOUT MEDICATION?

One in five Americans will experience a mental illness in a given year, according to the CDC. The stigma surrounding mental health makes it one of the most difficult medical issues to address. Enter the Fisher Wallace Stimulator. This FDA-approved, patient-directed technology, when used for 20 minutes once or twice a day, has been effective in treating depression, anxiety, and insomnia without medication. A live demo.

Kelly Roman, Co-founder and CEO, Fisher Wallace Laboratories

2:37 PM
GOING UPSTREAM TO TACKLE MENTAL HEALTH

A behind-the-curtain look at a brand new, cutting-edge program that’s taking mental well-being to the next level. A discussion between Dr. Lloyd Minor of Stanford Medicine and Arianna Huffington of Thrive Global about how their collaboration is going upstream, intervening to address mental health issues before they become more serious.

Dr. Lloyd Minor, Carl and Elizabeth Naumann Dean, Stanford University School of Medicine
Interviewer: Arianna Huffington, Thrive Global

2:47 PM
WHERE MENTAL HEALTH MEETS TECHNOLOGY

A conversation about how technology can help diagnose mental disorders sooner, identify optimal treatments faster and ultimately help more people lead healthier, happier lives. We’ll also explore the link between our society’s ubiquitous technology and mental health. How do we strike the right balance in using tech for good and controlling our devices, rather than the other way around?

Diesel Peltz, Founder and CEO, Twenty
Catherine Price, Science Journalist and Author, How to Break Up With Your Phone
Dr. Leanne Williams, Professor, Psychiatry and Behavioral Sciences, Stanford University
Moderator: Arianna Huffington, Thrive Global

3:12 PM
A CALL TO GLOBAL ACTION

27 million. That’s how many lives have been saved by The Global Fund in its quest to end the epidemics of AIDS, tuberculosis, and malaria. This partnership—between governments, civil society, the private sector, and those living with these diseases—invests close to $4 billion a year. A firsthand account from The Global Fund’s Executive Director Peter Sands about how this nonprofit supports those most in need at the grassroots level… and how you too can help.

Peter Sands, Executive Director, The Global Fund for AIDS, Tuberculosis and Malaria

3:20 PM
BREAK
3:40 PM
STARTUPS ON THE ROAD TO REVOLUTION? YOU BE THE JUDGE

Imagine a world where all your critical health data is safe from cyberattacks and affordable pharmaceuticals are available at the swipe of your finger. From patient billing to inventory management and faster drug discovery, hear from some of the world’s hottest startups about how they are transforming the future of health care.

Dave Hodgson, Co-founder and CEO, Project Ronin
Dr. Tim Junio, Co-founder and CEO, Expanse
Dr. Florian Otto, Co-founder and CEO, Cedar
Alice Zhang, Chief Executive Officer, Verge Genomics
Moderator/MC: Ellen McGirt, Senior Editor, FORTUNE

4:05 PM
WHEN EVERY BUSINESS IS A HEALTH CARE BUSINESS

Whatever line of business you’re in is a health care business says Jeff Immelt. The former chairman and CEO of GE shares why-and how-CEOs can become smarter health care consumers.

Jeff Immelt, Board Member, Collective Health; Venture Partner, NEA
Interviewer: Alan Murray, FORTUNE

4:18 PM
BETTING ON THE NEW TECH

The health care sector is ground zero for some of the biggest advances in tech today. Everything from blockchain to artificial intelligence and cloud computing has a place in the health care ecosystem. A conversation about where the smart money is and how investors should bet on the newest tech in the health care space.

Cheri Mowrey, Managing Director, Healthcare Services Investment Banking, Morgan Stanley
Dr. Beth Seidenberg, Founding Managing Director, Westlake Village BioPartners
Amit Sinha, Managing Director, Global Head of Biotechnology Investment Banking, Goldman Sachs
Moderator: Adam Lashinsky, Executive Editor, FORTUNE

4:42 PM
SPECIAL CLOSING INTERVIEW WITH EDIE FALCO

When she was diagnosed with breast cancer at the age of 40, actress Edie Falco says she felt frozen, paralyzed by the battle ahead of her. One year later, the Sopranos star found herself cancer-free and ready to start a family. Her healthy lifestyle and positive outlook carried her through her treatments to a place where Falco, now a single mother of two, is prepared to accept any of life’s surprises. Join us for an intimate conversation with the Emmy winner about how she beat cancer.

Edie Falco, Emmy Award-winning Actress, The Sopranos, Nurse Jackie
Interviewer: Arianna Huffington, Thrive Global

5:00 PM
ADJOURN AND CLOSING RECEPTION

Wednesday, April 3, 2019

5:00 PM
CLOSING RECEPTION
6:00 PM
ADJOURN